Sector: Pharmaceuticals & Biotechnology
|Large Cap
Zydus Lifesciences Share Price
Zydus Lifesciences Ltd.
₹1,077
Invest in ZYDUSLIFE with up to 4.00x margin.
Trade with MTFZydus Lifesciences Performance
Price Movement
₹1066.35
₹1083.25
1 Year Performance
₹835.50
₹1093.65
Markets Today
Historical Performance
Zydus Lifesciences Fundamentals
Zydus Lifesciences Financials
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 3,740.90 | 2,283.60 | 2,871.20 | 2,588.30 | 5,819.60 |
| Operating Expense | 1,751.80 | 2,084.60 | 1,719.30 | 2,002.90 | 2,046.90 |
| Operating Profit | 1,989.10 | 199 | 1,151.90 | 585.40 | 3,772.70 |
| Depreciation | 150.90 | 144.30 | 136 | 130 | 128 |
| Interest | 115.50 | 116 | 113.80 | 137.60 | 155.40 |
| Tax | 389 | 55.90 | 287 | 90.20 | 861 |
| Net Profit | 1,722 | 296.50 | 1,156.60 | 384.70 | 2,813.70 |
Zydus Lifesciences Technicals
Zydus Lifesciences Ltd. EMA & SMA
₹1077.00
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
Zydus Lifesciences Support and Resistance
Resistance
Support
Technical Indicators
Zydus Lifesciences Shareholding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 7.5 | 7.3 | 7.1 | 7.3 | 7.1 | 7 |
| DII | 10.7 | 11 | 11.2 | 10.9 | 11 | 11.2 |
| Public | 6.8 | 6.7 | 6.7 | 6.8 | 6.9 | 6.9 |
Zydus Lifesciences Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 13.41 L | 24.77 L | 54.16% |
| Week | 15.88 L | 52.76 L | 30.10% |
| 1 Month | 7.68 L | 22.61 L | 33.98% |
| 6 Month | 4.01 L | 9.51 L | 42.20% |
Zydus Lifesciences SWOT Analysis
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
Dividend yield greater than sector dividend yield
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
RSI indicating price strength
Top Gainers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Zydus Lifesciences Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 25 Jul, 2025 | 11 | FINAL | 25 Jul, 2025 | Equity Share |
| 26 Jul, 2024 | 3 | FINAL | 26 Jul, 2024 | Equity Share |
| 28 Jul, 2023 | 6 | FINAL | 28 Jul, 2023 | Equity Share |
| 28 Jul, 2022 | 2.5 | FINAL | 29 Jul, 2022 | Equity Share |
| 28 Jul, 2021 | 3.5 | FINAL | Equity Share | |
| 23 Mar, 2020 | 3.5 | INTERIM | 24 Mar, 2020 | Equity Share |
| 25 Jul, 2019 | 3.5 | FINAL | Equity Share | |
| 31 Jul, 2018 | 3.5 | FINAL | Equity Share | |
| 16 Mar, 2017 | 3.2 | INTERIM | 17 Mar, 2017 | Equity Share |
| 17 Mar, 2016 | 3.2 | INTERIM | 18 Mar, 2016 | Equity Share |
Zydus Lifesciences Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹770.85 | ₹1,138.40 | ₹1,811.40 | ₹1,705 | ₹2,409.60 | ₹178.59 |
| % Change | 0.72% | -3.19% | 0.25% | -1.92% | -1.95% | -0.48% |
| Revenue TTM (₹ Cr) | ₹2,124.33 | ₹2,192.49 | ₹1,421.59 | ₹9,203.54 | ₹14,277.64 | ₹8,869.07 |
| Net Profit TTM (₹ Cr) | ₹591.79 | ₹348.91 | ₹-73.80 | ₹924.36 | ₹1,912.93 | ₹-325.93 |
| PE TTM | 73.50 | 69.40 | -280.50 | 34.80 | 52.30 | -72.90 |
| 1 Year Return | 35.48 | 58.65 | 7.05 | 32.24 | -0.36 | -12.89 |
| ROCE | 27.56 | 18.38 | 0.59 | 25.65 | 14.32 | 2.29 |
Similar Stocks
ACUTAAS
Acutaas Chemicals Ltd.
₹ 3025.00
+3.46%
GLAND
Gland Pharma Ltd.
₹ 2302.40
-1.35%
LAURUSLABS
Laurus Labs Ltd.
₹ 1371.10
+1.09%
ALKEM
Alkem Laboratories Ltd.
₹ 5390.00
-0.19%
BIOCON
Biocon Ltd.
₹ 435.25
+1.21%
DIVISLAB
Divi's Laboratories Ltd.
₹ 6743.00
-0.20%
AJANTPHARM
Ajanta Pharma Ltd.
₹ 3098.50
+0.55%
GLENMARK
Glenmark Pharmaceuticals Ltd.
₹ 2359.00
+0.94%
WOCKPHARMA
Wockhardt Ltd.
₹ 1715.10
+4.73%
AUROPHARMA
Aurobindo Pharma Ltd.
₹ 1457.50
+0.20%
NATCOPHARM
Natco Pharma Ltd.
₹ 1190.00
+1.45%
SUNPHARMA
Sun Pharmaceutical Industries Ltd.
₹ 1842.50
+0.10%
NEULANDLAB
Neuland Laboratories Ltd.
₹ 17117.00
+2.14%
IPCALAB
Ipca Laboratories Ltd.
₹ 1579.80
+0.56%
JBCHEPHARM
J B Chemicals & Pharmaceuticals Ltd.
₹ 2191.50
-1.66%
ASTRAZEN
AstraZeneca Pharma India Ltd.
₹ 9025.00
+2.56%
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2282.00
-0.79%
PFIZER
Pfizer Ltd.
₹ 4636.90
-1.12%
ABBOTINDIA
Abbott India Ltd.
₹ 27605.00
-0.36%
TORNTPHARM
Torrent Pharmaceuticals Ltd.
₹ 4447.00
-2.75%
LUPIN
Lupin Ltd.
₹ 2256.00
-1.36%
DRREDDY
Dr. Reddy's Laboratories Ltd.
₹ 1329.60
-0.14%
CIPLA
Cipla Ltd.
₹ 1418.70
+0.34%
FAQ's on ZYDUSLIFE
What is the current share price of Zydus Lifesciences Ltd.?
What is the Market Capitalization of Zydus Lifesciences Ltd.?
What are the PE and PB ratios for Zydus Lifesciences Ltd.?
What is the 52-Week High and Low for Zydus Lifesciences Ltd.?
What is the current dividend yield for Zydus Lifesciences Ltd.?
Who are the major shareholders of Zydus Lifesciences Ltd.?
- Promoter
- FII
- Public
- Other Institutions
- Mutual Funds
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Zydus Lifesciences Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Zydus Lifesciences Ltd.?
By signing up I certify terms, conditions & privacy policy